Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Augustus Rush

Psychiatry Dallas, TX Medical Doctor

NPI 1720040991 CMS profile 350860

5323 Harry Hines Blvd, Dallas, TX 75390

Open in the dashboard

General payments

$759,556

508 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Augustus Rush of Dallas, TX is reported in the CMS Open Payments database as having received $759,556 across 508 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $214,235 247
2024 General $181,629 110
2023 General $75,009 27
2022 General $64,929 28
2021 General $46,538 24
2020 General $75,660 25
2019 General $101,556 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Augustus Rush
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Augustus Rush were reported at $214,235. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Augustus Rush Psychiatry median Middle half National median
2019 $101,556 $184 $59–$605 $163
2020 $75,660 $119 $36–$372 $114
2021 $46,538 $143 $43–$576 $132
2022 $64,929 $153 $50–$590 $149
2023 $75,009 $170 $56–$651 $160
2024 $181,629 $179 $57–$673 $164
2025 $214,235 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $607,365 423 payments
  2. Otsuka Pharmaceutical Development & Commercialization, Inc. $57,264 31 payments
  3. Janssen Research & Development, LLC $36,300 5 payments
  4. Janssen Pharmaceuticals, Inc $21,007 27 payments
  5. Otsuka America Pharmaceutical, Inc. $15,015 7 payments
  6. Janssen Scientific Affairs, LLC $13,625 7 payments
  7. Highridge Medical LLC $8,700 3 payments
  8. NuVasive, Inc. $258 3 payments
  9. CPM Medical Consultants, LLC $22 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $544,448 384 payments
  2. Consulting Fee $203,080 75 payments
  3. Honoraria $5,200 1 payment
  4. Travel and Lodging $4,918 12 payments
  5. Food and Beverage $1,910 36 payments
Products named General payments · program years 2019–2025
  1. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR Neurology $383,289 350 payments
  2. VNS Therapy Symmetry Model 8103 Generator Cardiology/Vascular Diseases $114,146 33 payments
  3. VNS Therapy $76,719 30 payments
  4. SPRAVATO $39,432 37 payments
  5. VNS - Symmetry $25,891 9 payments
  6. ABILIFY MYCITE $13,191 11 payments
  7. Vital $8,700 3 payments
  8. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $7,320 1 payment
  9. XLIF $258 3 payments
  10. URIST NMP $22 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

508 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record